Clinical Trials Directory

Trials / Completed

CompletedNCT02823613

The Influence of High and Low Salt on Exosomes in the Urine

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of Southern Denmark · Academic / Other
Sex
Male
Age
20 Years – 40 Years
Healthy volunteers
Accepted

Summary

The hypothesis is that changes in the epithelial sodium channel (ENaC) in the kidney is reflected in urinary exosomes and that the amount of ENaC as well as the cleavage degree is upregulated in conditions with low salt.

Detailed description

Methods: Exosomes will be isolated from spot urine by ultracentrifugation and tested using western blotting. In-house developed antibodies against different parts of the ENaC gamma subunit as well as commercial antibodies will be used. A marker for exosomes will validate the presence of exosomes in the urine. Power considerations: In this cross over salt-intervention study with quantification of ENaC the investigators refer to a published study regarding the sodium-chloride co-transporter (NCC) in the kidney, were rats where given aldosterone infusion or a low salt diet. In this study n=6 was sufficient to detect a 2-3 fold change in NCC in urinary exosomes. Furthermore 5 patients with primary aldosteronism had a significant increase in NCC in urinary exosomes (N. Lubbe et al, Hypertension 2012). On the basis of this the investigators choose to test 10 persons, but are not able to make a regular power calculation.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHigh salt diet followed by low salt dietHigh salt diet (250 mmol/day) in 5 days followed by low salt diet (60-70 mmol/day) in 5 days.
DIETARY_SUPPLEMENTLow salt diet followed by high salt dietLow salt diet (60-70 mmol/day) in 5 days followed by high salt diet (250 mmol/day) in 5 days.

Timeline

Start date
2016-08-01
Primary completion
2019-05-01
Completion
2019-05-23
First posted
2016-07-06
Last updated
2020-04-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02823613. Inclusion in this directory is not an endorsement.